Agarwala Sandip
Insider CIK 1845965 · TALS Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TALS Talaris Therapeutics, Inc. | A Award deriv | 2023-06-13 | 2023-06-14 | 20,500 | — | $0 | 20,500 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | A Award deriv | 2022-06-09 | 2022-06-13 | 14,501 | — | $0 | 14,501 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion deriv | 2021-05-11 | 2021-05-11 | 1,271,027 | — | $0 | 0 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion deriv | 2021-05-11 | 2021-05-11 | 1,308,410 | — | $0 | 0 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion deriv | 2021-05-11 | 2021-05-11 | 406,338 | — | $0 | 0 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | P Buy | 2021-05-11 | 2021-05-11 | 235,000 | $17.00 | $4.00M | 3,220,775 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion | 2021-05-11 | 2021-05-11 | 2,985,775 | — | $0 | 2,985,775 | SEC↗ |